Global Markets for Drug Repurposing
The global market for drug repurposing will grow from nearly $24.4 billion in 2015 to nearly $31.3 billion by 2020, with a compound annual growth rate (CAGR) of 5.1% for the period of 2015-2020.
The U.S. dominated the drug repurposing market and should reach approximately $13.7 in 2015 and close to $17.9 billion by 2020, rising at a CAGR of 5.4%.
The non-U.S. market is expected to increase from $ 10.6 billion in 2015 to nearly $13.4 billion by 2020 with a CAGR of 4.7%.
More Publications
The 2027-2032 World Outlook for Drug Repurposing
US$ 1,195.00
January 2026
287 pages
Cathepsin S (CTSS or EC 3.4.22.27) - Pipeline Review, H2 2019
US$ 3,500.00
December 2019
34 pages
Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Pipeline Review, H2 2018
US$ 3,500.00
July 2018
68 pages
Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) - Pipeline Review, H2 2018
US$ 3,500.00
July 2018
41 pages
